Currently, very little is known about the impact of COVID-19 on reproduction and pregnancy. But as the COVID 19 pandemic began to affect lives around the world, out of an abundance of caution, the ASRM task force released a mandate on March 17th, 2020 recommending fertility clinics to suspend all new infertility treatments, cancel embryo transfers,…

Is the new practice of social distancing or reducing close physical proximity with others contributing to another deadly epidemic, that of social isolation and loneliness? As the world grapples with COVID-19, the population worldwide is escalating into negative psychological reactions like stress, adjustment disorder and depression. Feeling under p…

COVID 19 is now a global pandemic.The cases of coronavirus are increasing rapidly across the world with the count crossing 246,005 globally and increasing every day. The virus, which originated from China, has rapidly spread to about 160 countries.This is a critical time for information, support and reassurance that science and evidence can offer. …

Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. Several types of immunotherapy are used to treat cancer. These treatments either re-engineer the immune cells or empower them to launch an attack on the cancer directly. Immunotherapy has led to remarkable results for some cancers, eradicating difficult-to-treat…

Eating disorders (ED) are serious and sometimes fatal illnesses that cause the sufferers to become obsessed with food, body weight and shape, and severely disturb their eating behaviour. Common eating disorders include binge eating disorder, bulimia nervosa, and anorexia nervosa. Recent research around the neurobiology of eating disorders has chang…

A mother’s immune system is altered during pregnancy so that the fetus is not rejected by her body and is allowed to grow. When this balance goes awry, the immune system may become the cause of a miscarriage or multiple miscarriages. We are talking to Dr. Jeffrey Braverman, a world leader in reproductive immunology, about the role of immune system …

FDA approval of the breakthrough CAR-T cell therapy for cancer brings the first approved gene therapy treatment to the United States. It reprograms the body's own immune system to recognize and kill cancer cells. The therapy initially called CAR-T cell immunotherapy and now named Kymriah by Novartis, is approved to treat children and young adults w…

At all stages of and levels of prostate cancer, whether you have low, intermediate, or high risk disease, whether you are newly diagnosed, have recurrent disease or your prostate cancer has advanced and metastasized, the same questions arise. What is the right treatment for me? Do I need this treatment? Do the benefits of treatment outweigh the ris…

FDA recently approved daratumumab (Darzalex) to treat patients with multiple myeloma who have received atleast three prior treatments. Daratumumab is the first monoclonal antibody approved for treating myeloma and provides another treatment option for patients who have become resistant to other therapies. Our myeloma panel is talking to the father …

We are what we eat. But what do we eat? Should we be eating meat? Or is a plant based diet a healthier way of eating? To provide some clarity on the subject we have Dr. Colin Campbell, the author of The China Study again with us on CureTalks. Dr. Campbell is going to present his views and studies linking cancer and nutrition, plant based diet, and …

We are what we eat. But what do we eat? Should we be eating meat? Or is a plant-based diet a healthier way of eating? Searching for answers on the World Wide Web inevitably leads to more questions, making us even more confused. Are supplements beneficial, or a waste of money? Are there certain principles of nutrition that everyone should followor d…

Multiple Myeloma Update From the 2014 American Society of Hematology (ASH) Annual Meeting, December 2014 - This program features expert physicians Joseph R. Mikhael, MD, MEd, FRCPC, FACP, and Suzanne Lentzch, MD, PhD. The presenters discuss the latest multiple myeloma data presented during the 2014 ASH Annual Meeting held in Orlando, FL.…

Multiple Myeloma Highlights from the 2014 ASH Annual Meeting, December 2014 - This program features expert physicians Sundar Jagannath, MD, from Mt. Sinai Hospital in New York, NY, and Robert Z. Orlowski, MD, PhD, from MD Anderson Cancer Center in Houston, TX. The presenters discuss and highlight major developments in myeloma research and treatment…

In the absence of a proven cure for EBOLA, researchers across the country are in a frenzy to get the one vaccine which can prevent the spread of this deadly disease and also provide people offering medical care to the infected, protection from contracting the infection themselves. When are we getting this vaccine and why is there a greater buzz on …

Highlights From the 2014 ASCO and EHA Annual Meetings, July 2014 - This program features expert physicians Meletios-Athanassios Dimopoulos, MD, from University of Athens in Athens, Greece, and Paul G. Richardson, MD, from the Dana-Farber Cancer Institute in Boston, MA. The presenters discuss and highlight major developments in myeloma research and …

We are beginning our series on Cancer and Exercise this June with a discussion on how exercise can help cancer patients/survivors. The discussion will be co-hosted by prostate cancer survivor and advocate Richard Davis. We have an amazing panel of experts - Dr. Donald Abrams and Dr. June Chan from UCSF, Dr. Lee Jones from MSKCC, and cancer fitness …

Multiple Myeloma Update From the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting, June 2014 - This program features expert physicians Antonio Palumbo, MD and Noopur Raje, MD,. The presenters discuss the latest multiple myeloma data presented during the 2014 ASCO Annual Meeting held in Chicago, IL.…

Dr. Donald Abrams is back on Cure Panel and we are discussing 'Cannabis for Cancer' Dr. Donald I. Abrams is a cancer and integrative medicine specialist at the UCSF Osher Center for Integrative Medicine at Mount Zion. Abrams provides integrative medicine consultations for cancer patients and has completed research in complementary and alternative t…

Our talk series on YOGA is discussing Meditation with Dr. Richard Miller, Founder of iREST (http://www.irest.us/). Dr.Miller, is a clinical psychologist, author, researcher, yogic scholar and spiritual teacher. Richard is the founding president and CEO of the Integrative Restoration Institute, co-founder of The International Association of Yoga The…

We are excited to feature Dr. Vincent Rajkumar of Mayo Clinic on The Cure Panel Talk Show. Dr. Rajkumar will be addressing the topic, Myeloma Control vs. Cure with our panel of patient experts. Dr. S. Vincent Rajkumar is a professor of medicine at the Mayo Clinic in Rochester, Minnesota. His research focuses on clinical, epidemiological, and labora…

Highlights From the 2013 ASH Annual Meeting, January 2014 - This program features expert physicians Amrita Krishnan, MD, FACP, from City of Hope in Duarte, CA, and Joseph Mikhael, MD, MEd, FRCPC, FACP, from May Clinic in Scottsdale, AZ. The presenters discuss and highlight major developments in myeloma research and treatments for newly diagnosed an…

Clinical Insights, November 2013 - This presentation, featuring Amrita Krishnan, MD, FACP, provides information about the role of stem cell transplantation in the treatment of multiple myeloma.

Clinical Insights, November 2013 - This presentation features Anne Quinn Young, MPH from the Multiple Myeloma Research Foundation providing an overview about the MMRF and the Clinical Insights in Multiple Myeloma program.

Clinical Insights, November 2013 - This presentation, featuring Joseph Mikhael, MD, MEd, FRCPC, FACP, provides information about prognosis and risk in the treatment of multiple myeloma.

Clinical Insights, November 2013 - This presentation, featuring A. Keith Stewart, MBChB, provides information about treatment options for newly diagnosed patients with multiple myeloma.

Clinical Insights, November 2013 - This presentation, featuring Thomas G. Martin, MD, provides information about the latest treatments for relapsed/refractory multiple myeloma.

Clinical Insights, November 2013 - This presentation, featuring Angela Mayo, MS, PA-C, provides information about the is supportive care options in multiple myeloma.

Clinical Insights, November 2013 - This presentation, featuring Joseph Mikhael, MD, MEd, FRCPC, FACP, provides information about the is role of clinical trials in the treatment of multiple myeloma.

Clinical Insights, November 2013 - This presentation features a panel discussion and question and answer session with top myeloma experts discussing current topics impacting multiple myeloma patients.

Multiple Myeloma Update From the 2013 American Society of Hematology (ASH) Annual Meeting, December 2013 - This program features expert physicians Ola Landgren, MD, PhD, and Maria-Victoria Mateos, MD, PhD who discuss key findings in myeloma research including updates on new myeloma therapies, stem cell transplantation, and maintenance therapy as pr…

Clinical Insights, June 2013 - This presentation, featuring Kenneth C. Anderson, MD, provides information about the is role of clinical trials in the treatment of multiple myeloma.

Clinical Insights, June 2013 - This presentation, featuring Noopur Raje, MD, provides information about the is supportive care options in multiple myeloma.

Clinical Insights, June 2013 - This presentation, featuring Kenneth C. Anderson, MD, provides information about the latest treatments for relapsed/refractory multiple myeloma.

Clinical Insights, June 2013 - This presentation, featuring Jacob Laubach, MD, MPP, provides information about treatment options for newly diagnosed patients with multiple myeloma.

Clinical Insights, June 2013 - This presentation, featuring Nikhil C. Munshi, MD, provides information about prognosis and risk in the treatment of multiple myeloma.

Clinical Insights, June 2013 - This presentation features Daniel Auclair, PhD, from the Multiple Myeloma Research Foundation providing an overview about the MMRF and the Clinical Insights in Multiple Myeloma program.

The Cure Panel Talk Show is excited to host Myeloma Survivor and Baseball Coach Don Baylor (Arizona Diamondbacks) and eminent myeloma specialist Dr. James R. Berenson from IMBCR on June 20 along with noted myeloma author and survivor Pat Killingsworth. The show will be co-hosted by myeloma survivor Matt Goldman and the topic of discussion is IMPACT…

Multiple Myeloma Update From the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting, June 2013 - This program features expert physicians Robert Z. Orlowski, MD, PhD, Jesus F. San Miguel, MD, PhD, and Donna E. Reece, MD. The presenters discuss the latest multiple myeloma data presented during the 2013 ASCO Annual Meeting held in Chicag…

Cure Panel Talk Show will host David Emerson from Justice Resource Institute on 13 June @ 6pm EST for a discussion on YOGA for TRAUMA with yoga teachers and experts, Dashama, Micheline Toussaint, and Marcela Clavijo.由CureTalks

Dr. Anil Patri, Deputy Director, Nanotechnolgy Characterization Laboratory, NCI is the featured speaker on June 11 on The Cure Panel Talk Show. Dr. Patri will be addressing the interesting topic of Nanotechnology in Oncology.由CureTalks

Clinical Insights, June 2013 - This presentation, featuring Phillip L. McCarthy, MD, provides information about the role of stem cell transplantation in the treatment of multiple myeloma.

Cure Panel Talk Show is honored to host Dr. Mark A. Rubin of Weill Cornell Medical College. The show will be co-hosted by Dan Zenka VP (Communications), Prostate Cancer Foundation and on the panel are Dan Hennessey, Paul Henshall, and Jim Wickstrom. Cure Panel Talk Shows on Prostate Cancer are coordinated by Priya Menon of CureTalk, Blog of TrialX,…

Highlights From the 13th International Myeloma Workshop, May 2013 - Learn about the latest in multiple myeloma treatment presented at the 13th International Myeloma Workshop in Kyoto, Japan.

New Treatment Options in Multiple Myeloma, February 2013 - Learn about some of the latest breakthrough treatments in multiple myeloma such as Pomalyst (pomalidomide), Kyprolis (carfilzomib), and subcutaneous Velcade (bortezomib) from our panel of experts.